6661 logo

Welgene Biotech Co.,Ltd. Stock Price

TPEX:6661 Community·NT$437.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6661 Share Price Performance

NT$18.75
-5.05 (-21.22%)
NT$18.75
-5.05 (-21.22%)
Price NT$18.75

6661 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet and fair value.

2 Risks
2 Rewards

Welgene Biotech Co.,Ltd. Key Details

NT$365.8m

Revenue

NT$212.9m

Cost of Revenue

NT$152.8m

Gross Profit

NT$151.2m

Other Expenses

NT$1.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.07
41.79%
0.45%
55.5%
View Full Analysis

About 6661

Founded
2003
Employees
n/a
CEO
Yi Xing Lin
WebsiteView website
www.welgene.com.tw

Welgene Biotech Co.,Ltd. provides genetic testing services. The company offers research services, including sequencing, microarray, qPCR verification, nucleic acid extraction/QC, LCM single cell experiment, and bioinformatics analysis services; and Cytoscan, an array-based comparative genomic hybridization. It also provides reagents, consumable supplies, and instruments, as well as software services. The company was founded in 2003 and is based in Taipei City, Taiwan.

Recent 6661 News & Updates

Recent updates

No updates